Cue Biopharma, Inc.CUENASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank30
3Y CAGR-22.7%
5Y CAGR-15.8%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-22.7%/yr
vs +19.1%/yr prior
5Y CAGR
-15.8%/yr
Recent deceleration
Acceleration
-41.8pp
Decelerating
Percentile
P30
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$42.21M+31.1%
2024$32.19M-47.7%
2023$61.53M-32.6%
2022$91.28M+9.5%
2021$83.40M-16.2%
2020$99.53M+39.0%
2019$71.61M+57.8%
2018$45.36M-32.2%
2017$66.95M+311.3%
2016$16.28M-